44 related articles for article (PubMed ID: 21157159)
1. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
Brandom BW; Bina S; Wong CA; Wallace T; Visoiu M; Isackson PJ; Vladutiu GD; Sambuughin N; Muldoon SM
Anesth Analg; 2013 May; 116(5):1078-1086. PubMed ID: 23558838
[TBL] [Abstract][Full Text] [Related]
2. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.
Kim JH; Jarvik GP; Browning BL; Rajagopalan R; Gordon AS; Rieder MJ; Robertson PD; Nickerson DA; Fisher NA; Hopkins PM
Anesthesiology; 2013 Nov; 119(5):1054-65. PubMed ID: 24013571
[TBL] [Abstract][Full Text] [Related]
3. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
[TBL] [Abstract][Full Text] [Related]
4. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of RYR1 variants identified in malignant hyperthermia susceptible individuals.
Noda Y; Miyoshi H; Benucci S; Gonzalez A; Bandschapp O; Girard T; Treves S; Zorzato F
Neuromuscul Disord; 2023 Dec; 33(12):951-963. PubMed ID: 37996280
[TBL] [Abstract][Full Text] [Related]
6. Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility.
van den Bersselaar LR; van Alfen N; Kruijt N; Kamsteeg EJ; Fernandez-Garcia MA; Treves S; Riazi S; Yang CY; Malagon I; van Eijk LT; van Engelen BGM; Scheffer GJ; Jungbluth H; Snoeck MMJ; Voermans NC
J Neuromuscul Dis; 2023; 10(4):541-554. PubMed ID: 37154182
[TBL] [Abstract][Full Text] [Related]
7. Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene.
Clayton JS; Vo C; Crane J; Scriba CK; Saker S; Larmonier T; Malfatti E; Romero NB; Ravenscroft G; Laing NG; Taylor RL
Stem Cell Res; 2024 Jun; 77():103410. PubMed ID: 38583293
[TBL] [Abstract][Full Text] [Related]
8. BMI and malignant hyperthermia pathogenic ryanodine receptor type 1 sequence variants in Switzerland: A retrospective cohort analysis.
Gonzalez A; Girard T; Dell-Kuster S; Urwyler A; Bandschapp O
Eur J Anaesthesiol; 2021 Jul; 38(7):751-757. PubMed ID: 33259453
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in RYR1 are associated with foetal akinesia deformation sequence/lethal multiple pterygium syndrome.
McKie AB; Alsaedi A; Vogt J; Stuurman KE; Weiss MM; Shakeel H; Tee L; Morgan NV; Nikkels PG; van Haaften G; Park SM; van der Smagt JJ; Bugiani M; Maher ER
Acta Neuropathol Commun; 2014 Dec; 2():148. PubMed ID: 25476234
[TBL] [Abstract][Full Text] [Related]
10. Episodic RYR1-Related Crisis: Part of the Evolving Spectrum of RYR1-Related Myopathies and Malignant Hyperthermia-Like Illnesses.
Dowling JJ; Riazi S; Litman RS
A A Pract; 2021 Jan; 15(1):e01377. PubMed ID: 33512901
[No Abstract] [Full Text] [Related]
11. Detection of the T1640C
Haluskova J; Holeckova B; Kokulova L; Galdikova M; Bucan J; Schwarzbacherova V; Sedlakova S
Vet Med (Praha); 2023 Nov; 68(11):428-434. PubMed ID: 38163044
[TBL] [Abstract][Full Text] [Related]
12. Rapid screening for mutations associated with malignant hyperthermia using high-resolution melting curve analysis.
Su IM; Wang PK; Chen CY; Huang HT; Day YJ
Tzu Chi Med J; 2021; 33(4):399-405. PubMed ID: 34760638
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program: Erratum.
Anesthesiology; 2024 May; 140(5):1057. PubMed ID: 38376144
[No Abstract] [Full Text] [Related]
14. Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant.
Herdewyn S; De Bleecker J; Janssens L; Symoens S; Milazzo M; De Puydt J
Neuromuscul Disord; 2024 Feb; 35():39. PubMed ID: 38237271
[No Abstract] [Full Text] [Related]
15. The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant.
Voermans NC; Yang C; Schouten M; Girard T; Stowell K; Riazi S; Kamsteeg EJ; Snoeck M
Neuromuscul Disord; 2024 Feb; 35():40-41. PubMed ID: 38007345
[No Abstract] [Full Text] [Related]
16. Gene Panel Sequencing Identifies a Novel
Moon YJ; Park J; Kim JR; Lee SY; Lee J; Cho YG; Kim DS
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292611
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Pathologic Findings of Korean Patients with RYR1-Related Congenital Myopathy.
Jeong HN; Park HJ; Lee JH; Shin HY; Kim SH; Kim SM; Choi YC
J Clin Neurol; 2018 Jan; 14(1):58-65. PubMed ID: 29629541
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia.
Kim DC
Korean J Anesthesiol; 2012 Nov; 63(5):391-401. PubMed ID: 23198031
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetic analysis of the ryanodine receptor gene (RYR1) in Korean malignant hyperthermia families].
Lee H; Kim DC; Lee JH; Cho YG; Lee HS; Choi SI; Kim DS
Korean J Lab Med; 2010 Dec; 30(6):702-10. PubMed ID: 21157159
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
